Menstrual Irregularity, Hormonal Contraceptive Use, and Bone Stress Injuries in Collegiate Female Athletes in the United States
Abstract
Background: Menstrual irregularity (MI) is common in female athletes and is a component of the Female Athlete Triad (Triad). Many athletes with the Triad are started on hormonal contraceptives (HC) for MI, but this interferes with the ability to monitor menstrual cycle regularity and can mask other causes of MI. There are limited studies investigating the relationship between MI, HC use, and injury in female collegiate athletes.Objective: To examine the prevalence of and relationship between HC use, MI, and bone stress injuries in female collegiate athletes in the United States.Design: Cross‐sectional study.Setting: Online survey.Participants: 1020 U.S. female collegiate athletes (age ≥ 18 years).Methods or Interventions: Assessment of risk factors for menstrual irregularity and bone stress injuries was conducted via a one‐time survey.Main Outcome Measures: HC use, MI, history of stress fractures.Results: Current HC use prevalence was 65% (95% confidence interval [CI], 61.9%, 67.8%). Of all athletes, 47% reported past MI. Of the athletes who were not currently using HCs, 32% had current MI. Compared with athletes without past MI, more athletes with past MI reported current HC use (73% vs. 57%) and indicated menstrual cycle consistency as the primary reason for use (24% vs. 4%) (P < .001). Additionally, 25% of athletes reported a history of stress fractures, which was associated with lean/aesthetic sports participation (odds ratio [95% CI]: 1.9 [1.4, 2.5]; P < .001) and less oral contraceptive pill (OCP) use (0.7 [0.5, 1.0]; P = .043). Compared with OCPs, injectable HCs were associated with greater odds of a history of stress fractures (4.5[1.6, 12.3]; P = .004).Conclusions: HC use was prevalent among this cohort of female collegiate athletes, and almost half of the athletes reported past MI. A goal of menstrual cycle regularity was cited by 24% of athletes as a primary reason to use HCs, which shows that more athlete education is needed to avoid masking MI and the Triad with HCs. Further studies elucidating the relationship between HC use, MI, and sports‐related injury are warranted.Keywords
This publication has 50 references indexed in Scilit:
- History of oral contraceptive drugs and their use worldwideBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- Risk factors for stress fracture in female endurance athletes: a cross-sectional studyBMJ Open, 2012
- The Female Athlete TriadSports Health: A Multidisciplinary Approach, 2012
- Hormonal contraceptive practices in young Australian women (⩽25 years) and their possible impact on menstrual frequency and iron requirementsSexual & Reproductive Healthcare, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Characteristics of the Female Athlete Triad in Collegiate Cross-Country RunnersJournal of American College Health, 2007
- Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cyclesContraception, 2006
- Androgenic Progestins in Oral Contraceptives and the Risk of Epithelial Ovarian CancerObstetrics & Gynecology, 2005
- Risk Factors for Stress Fractures in Female Track-and-Field AthletesClinical Journal of Sport Medicine, 1995
- Menstrual irregularity and stress fractures in collegiate female distance runnersThe American Journal of Sports Medicine, 1988